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Abstract
Background: A school-based survey was undertaken to assess prevalence and infection intensity of schistosomiasis
in school-aged children in the Marolambo District of Madagascar.
Methods: School-aged children from six purposively selected schools were tested for Schistosoma haematobium by
urine filtration and Schistosoma mansoni using circulating cathodic antigen (CCA) and Kato-Katz stool analysis. The
investigators did not address soil-transmitted helminths (STH) in this study.
Results: Of 399 school-aged children screened, 93.7% were infected with S. mansoni based on CCA analysis.
Kato-Katz analysis of stool revealed S. mansoni infection in 73.6% (215/ 292). Heavy infections (> 400 eggs per
gram) were common (32.1%; 69/ 215), with a mean of 482 eggs per gram of stool. Moderate infection
intensities were detected in 31.2% (67/ 215) and light infection intensities in 36.7% (79/ 215) of infected
participants. No infection with S. haematobium was detected by urine filtration.
Conclusions: Intestinal schistosomiasis appears a considerable public health issue in this remote area of
Madagascar where there is a pressing need for mass drug administration.
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Background
Schistosomiasis is common in sub-Saharan Africa and is
known to be widespread in Madagascar where there is a
substantial burden of disease [1, 2]. There are two en-
demic species of Schistosoma, with a geographical distri-
bution tracking the underlying range of their permissive
snail hosts [3, 4]. Schistosoma mansoni causes intestinal
schistosomiasis and is found in eastern and southern
areas of Madagascar while S. haematobium, which
causes urogenital schistosomiasis, is present in northern
and western locations, with areas of co-endemicity in
four regions in north-central and south-western parts of
the country [5, 6]. National schistosomiasis mapping led
by the Madagascar Ministry of Health demonstrated that
107 of 114 districts in Madagascar are endemic with
schistosomiasis [6].
Schistosomiasis frequently leads to nonspecific effects
such as anaemia, undernutrition, decreased physical fit-
ness, impaired cognition and quality of life [7–10]; meas-
uring these is crucial in monitoring disease morbidity
[11]. Schistosoma mansoni in particular results in intes-
tinal and hepatosplenic disease causing abdominal pain,
blood in stool, reduced appetite and diarrhoea [12, 13].
In chronic disease states, hepatic fibrosis can develop 5–
15 years after initial infection, though earlier cases have
been documented in preschool children [14, 15]. This
may lead to portal hypertension which can precede
hepatosplenomegaly, ascites and gastro-oesophageal
bleeds that can be fatal if bleeding is uncontrolled [16].
In areas with intermittent access to treatment, such as
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Madagascar, re-infection occurs rapidly and results in
chronic schistosomiasis.
Schistosoma haematobium causes urogenital schisto-
somiasis, which often presents with haematuria. Other
presenting symptoms may include urinary frequency and
dysuria. Chronic infection results in fibrosis or calcifica-
tion of the bladder, which may cause obstruction of the
urinary tract leading to hydroureter or hydronephrosis.
Treatment can cure bladder lesions and obstructive dis-
ease; however, without treatment chronic urinary schis-
tosomiasis is associated with development of squamous
cell carcinoma of the bladder. Female genital schistosom-
iasis (FGS) is a result of S. haematobium causing localised
inflammation in the female genital tract. Symptoms may
include dyspareunia, stress incontinence and infertility.
Sandy patches in the lower genital tract are pathogno-
monic and are seen in association with altered vasculature.
Subsequent contact bleeding increases susceptibility to
HIV transmission in women with FGS [11, 17].
Preventative chemotherapy (PC) is an important public
health measure entailing the delivery of medications to en-
demic populations to reduce morbidity and transmission
rates of human helminth infections. Current schistosom-
iasis control activities focus on PC in the form of mass
drug administration (MDA) with praziquantel (PZQ).
Where the prevalence of infected school-aged children
(SAC) is greater than 50%, the World Health Organization
(WHO) recommends annual treatment to both SAC and
adults in high risk communities. In moderate risk areas,
where the prevalence amongst SAC is between 10 and
50%, MDA should be targeted towards all SAC every two
years as well as to adults considered to have a higher risk
of infection (such as fishermen, farmers and irrigation
workers) and to pregnant or lactating women. SAC who
live in regions with <10% prevalence should be treated
twice during their primary schooling age [18, 19]. Using
PC, the aim is control or elimination of schistosomiasis, as
well as other neglected tropical diseases (NTDs) such as
soil-transmitted helminthiasis (STH), onchocerciasis and
lymphatic filariasis [20, 21].
There are Ministry of Health (MOH)-led NTD control
programmes in 36 out of 107 affected districts in
Madagascar [20]. Prohibitive costs and logistical difficul-
ties prevent access to some districts. In more remote
areas the majority of roads and tracks are often unusable
during wet seasons and travel between villages is limited
to foot or boat [22]. In 2015 only 1.7 million (43.6%) of
the 3.8 million target population (SAC) in Madagascar
received PZQ [23]. In a recent WHO publication, the
coverage of PC to SAC for the African region was re-
ported to be 41.2%, and the MOH-led PC in Madagascar
is therefore above the regional average [24]. However,
the annual need for PC varies between districts accord-
ing to their prevalence, therefore a national approach
should be guided by the differing needs for PC through-
out the country. A recent paper reported on very high
prevalence rates and infection intensities of both uro-
genital and intestinal schistosomiasis in areas of western
Madagascar left untreated for over five years [25], indi-
cating the need for urgent up-scaling of national control
initiatives to 100% of the districts requiring PZQ. There
have also been detailed publications on high schistosom-
iasis prevalence rates from the central highlands and
western Madagascar [4, 26, 27].
The aim of this study was to investigate the pres-
ence, prevalence rates and infection intensities of S.
haematobium and S. mansoni among SAC in the East
of Madagascar. Here we report on a cross-sectional
survey in six villages within the Marolambo District
of the Atsinanana Region. This information highlights
high-risk transmission areas in which communities re-
quire urgent control initiatives and provides the base-
line information that is necessary to monitor the
impact of intervention programmes.
Methods
Study area and population
This work was conducted during June-July 2015 in col-
laboration with the MOH, Antananarivo, Madagascar.
Six villages in the Marolambo District were selected due
to their accessibility and their community links with our
collaborators, Durrell Wildlife Conservation Trust and
MOH staff. These villages lie next to the Nosivolo River
(Fig. 1), their main water source, and had not received
MDA since 2008.
Study design
Children aged 5–14 were selected from schools in six
villages. Urine samples were obtained from 399 children
and faecal samples from 292 children, which was the
maximum number of children we could test within our
fieldwork timeframe. Using school registers provided by
the headteachers, an equal number of boys and girls were
selected at random from each year group. This ensured an
even spread in age range throughout the sample frame and
equal gender representation. The numbers of valid urine
and faecal samples obtained from each village were: Am-
pasimbola (67 urine samples; 62 faecal samples), Ambohi-
telo (68; 69), Marofatsy (60; 57), Marolambo (84; 0),
Vohidamba (59; 53) and Betampona (61; 51).
Parasitology methods
The day before screening all children were provided with
a single stool sample container and assigned an identifi-
cation number, which was recorded with their age and
gender. Researchers instructed study participants on
how to collect their morning stool. The next day, sam-
ples were collected by researchers. At 10 am, children
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were provided with a single urine sample container la-
belled with the same identification number and were
instructed to collect a mid-stream urine sample. Chil-
dren returned samples promptly before 12 pm midday.
Stool and urine samples were brought to the field la-
boratory and processed by researchers on the same day.
For the detection of S. mansoni, a urine-cassette assay
was used to detect circulating cathodic antigen (CCA;
Rapid Medical Diagnostics Tests, Pretoria, South Africa).
Technicians were trained in Antananarivo in the use of
CCA tests following manufacturer’s instructions and all
results were verified by at least two technicians to ensure
homogeneity. CCA test band reaction intensity was re-
corded as negative (−), trace positive (tr), single positive
(+), double positive (++), or triple positive (+++) in line
with previous studies [28]. Results were analysed in a
binary fashion as negative or positive (including all posi-
tive recordings: tr; +; ++; +++). Urine samples were only
included in the study when they were of sufficient quan-
tity to assess using CCA.
To assess S. mansoni infection intensity, a single Kato-
Katz thick smear containing 41.7 mg of faeces was pre-
pared from each sample (Kato-Katz kit, Vestergaard-
Frandsen, Lausanne, Switzerland). Slides were examined
for S. mansoni eggs and any present were counted. This
value was used to calculate the total number of eggs per
gram (epg). Intensity of infection was classified by epg as
light (1–99 epg), moderate (100–399 epg) or heavy (≥
400 epg) [18]. Stool samples were only eligible for inclu-
sion when they were of sufficient size to prepare a single
thick smear.
For the detection of S. haematobium, urine samples
were first tested for microhaematuria using urine-
reagent strips, then 10 ml of each sample was filtered
using a 12-μm polycarbonate filter (Sterlitech Corpor-
ation, Kent, USA) and examined using light microscopy
to look for eggs. Only urine samples of at least 10 ml in
volume were included in the study.
Slides were prepared and examined in the field. This
was carried out by the four UK-based team members
Fig. 1 Sketch map of Marolambo showing locations of the villages screened alongside the Nosivolo River. Prevalence rates according to the CCA
and Kato-Katz diagnostic tests are labelled alongside each village
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(three medical students and one medical doctor) follow-
ing training from the University of Manchester Immun-
ology Department and the Liverpool School of Tropical
Medicine. For both S. mansoni and S. haematobium,
every tenth slide was re-examined by a second team
member and if a difference was identified a consensus
reached. The investigators did not address STH in this
study.
Statistical analyses
Results were recorded on paper in the field and later en-
tered into Microsoft Excel (Redmond, WA, US). Statis-
tical analysis was performed on Stata 13 (Stata Statistical
Software: Release 13. College Station, TX: StataCorp LP).
Bivariate analysis was performed to explore CCA re-
sults and infection intensity with age, controlling for
gender and village. The odds ratio, 95% confidence inter-
val (CI) and P were calculated for each model.
CCA results were compared to age using binary logis-
tic regression. Intensity of infection according to epg
(negative: 0, trace and single positive: 1, double positive:
2 and triple positive: 3) was simplified into 3 binary
scales with outcomes of < 0, < 1, and < 2 and a pooled
odds ratio for age calculated using ordinal logistic re-
gression. Results were considered significant if P < 0.05.
Due to the highly skewed distribution of epg, a Spear-
man’s rank correlation was used to test associations be-
tween age and infection intensity.
Consent and permissions
National and local health, educational and administrative
authorities were comprehensively informed of the study.
Before the start of the study in each village, open public
meetings were carried out in the Malagasy language
followed by question and answer sessions with the inves-
tigators. Participation information sheets and consent
forms were translated into Malagasy detailing all aspects
of the methodology and read to each participant in private
by head-teachers, local health workers, and Malagasy in-
vestigators. The children then had the option to stamp
with their fingerprint to consent to the study. It was ex-
plained that any child had the chance to withdraw from
the study at any point, without any consequence.
Results
In total 399 children aged 5–14 were sampled. Of faecal
samples, 215/292 (73.6%) were positive for S. mansoni
by Kato-Katz analysis (Table 1). Light infection intensity
was observed in 79/215 (36.7%) of infected participants,
moderate intensity in 67/215 (31.2%) and heavy intensity
in 69/215 (32.1%). Mean infection intensity across the
study cohort was 482 epg (range 24–4104 epg), with no
significant variation between genders. There was a non-
significant variation in prevalence by village (Fig. 1).
There was a positive correlation between S. mansoni epg
and age (Spearman’s rank correlation coefficient 0.21;
P < 0.05; Fig. 2), with an odds ratio of 1.18 for higher
epg with age (95% CI: 1.11–1.26). Multivariable analysis
adjusted for village and gender is shown in Table 2. No
data were recorded for quality control.
CCA analysis of the urine samples for S. mansoni re-
vealed a positive rate of 374/399 (93.7%). Of all positive
samples, trace and single positive graded infections were
found in 115/374 (31%), double positive in 128/374
(34%) and triple positive in 131/374 (35%). Analysis
showed a positive correlation between CCA grading
Table 1 Characteristics and results of study by age
Study characteristic Age (yrs)
5–6 7–8 9–10 11–12 13–14
Number of participants 64 85 85 79 83
Percentage female 53.13 51.76 50.59 51.90 46.99
Schistosomiasis prevalence (%) Kato-Katz 76.56 80.00 87.06 82.28 84.34
CCA 85.94 91.76 98.82 97.47 97.59










Sm + mean intensity (epg) per village Ampasimbola 108 516 473.5 757.3 1095.3
Ambohitelo 256 160 387.4 460.4 495
Marofatsy 96 664 192 693 656
Vohidamba 72 223.2 402.7 929 604.4
Betampona 144 487 691 384 366
Sm + mean intensity (epg) per gender Male 136 392.64 411.72 754.32 502.56
Female 147.6 362.64 498.32 850.08 732.8
Abbreviations: CCA circulating cathodic antigen, epg eggs per gram, Kato-Katz microscopy using the Kato-Katz technique
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of infection and age (binary regression model,
P < 0.05), with a pooled odds ratio of 1.26 for higher
CCA grading with age (95% CI: 1.07–1.48), adjusted
for site and gender.
With regards to urinary schistosomiasis, 399 urine
samples were analysed. There were 13/399 (3.2%) sam-
ples positive for microhaematuria and of these, all were
negative for S. haematobium eggs.
Discussion
This cross-sectional study demonstrates an alarmingly
high endemicity of S. mansoni infection in the Maro-
lambo District. Schistosoma mansoni eggs were detected
in faecal samples from 73.6% of children and 93.7% of
children had positive CCA tests. This high prevalence
could be explained by the lack of PC in these communi-
ties since 2008. We found that age had a strong positive
correlation with both prevalence and infection intensity
as demonstrated by both Kato-Katz and CCA. There
were no differences in either prevalence or infection in-
tensity between villages or genders.
As expected from its known distribution, S. haemato-
bium was not endemic. Although 13 samples (3.2%)
were positive for microhaematuria, urine filtration of
these samples revealed no infection with S. haemato-
bium. Microhaematuria may be attributed to a number
of alternative possible causes such as bacterial infection
of the urinary tract and inflammation, renal disease, ex-
ercise, trauma and menses.
The discrepancy in detection rates of S. mansoni be-
tween Kato-Katz and CCA seen here is well recognised;
sensitivity of single smears of Kato-Katz is lower than
that of CCA analysis. The low sensitivity associated with
Kato-Katz may be due to variations in the distribution of
schistosome eggs between stool samples and there may
be reduced detection rates in either light or recently ac-
quired infections [29–31]. One study limitation is that
single smears were taken for Kato-Katz analysis and it is
possible that low intensity infections were not identified,
though these are likely to have been picked up by CCA.
The high prevalence values seen in Marolambo are
comparable to other focal prevalence surveys in
Tanzania (64.3%) [16], Western Kenya (60.5%) [32] and
the Democratic Republic of the Congo (82.7%) [33]. Pre-
viously, similar remote-area expeditions have been car-
ried out in Madagascar by Howarth et al. [26] who
found an overall prevalence of 69% of S. haematobium
infection across two schools in the Ankilivalo District of
Western Madagascar. They found a marked increase in
prevalence from 13% in 1971 to 74% in 1988 in one
school where there had been the introduction of a new
irrigation system [26]. More recently, a survey was
Fig. 2 Schistosomiasis infection rates against the age groups tested
in this study. This figure demonstrates the increasing parasite load
with age (Spearman’s rank correlation coefficient 0.21, P < 0.05)
Table 2 Multivariable analysis of schistosomiasis prevalence and intensity of infection against age, adjusted for gender and location.
Odds ratio represents the increase for each year
Odds ratio 95% CI P Adj. odds
ratioa
95% CI P
EPG 1.18b (1.11–1.26) < 0.0005 1.18b (1.11–1.26) < 0.0005
CCA 1.27c (1.09–1.49) 0.003 1.26c (1.07–1.48) 0.005
Abbreviations: CCA circulating cathodic antigen, EPG eggs per gram
aOdd ratio adjusted for sex and site
bPooled odds ratio from an ordinal logistic regression of 3 binary outcomes (> 0, > low, > moderate)
cOdds ratio from a binary logistic regression
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carried out in 2015 across randomly selected sites un-
treated for at least five years in western Madagascar.
The study revealed S. haematobium infection prevalence
rates higher than 90% in some locations, and higher than
80% prevalence of S. mansoni infection in one location
(Mitia-Est) [25]. Other recent studies in central
Madagascar in the Amoron’i Mania region have found S.
mansoni infection rates of 77.1% in schools in the
Ampasina village, Ambositra [27] and 68.3% in the Teti-
kanana village, Ambatofinandrahana [34]. Our results
from SAC in Marolambo demonstrate that schistosomia-
sis is hyperendemic in another untreated population in
Madagascar and provides evidence for the need to include
Marolambo in the national NTD programme for PC.
The extremely high prevalence rates found in our study
may explain the non-significant differences between vil-
lages. Small variations could represent access to adequate
water, sanitation and hygiene (WASH) facilities in schools,
as well as social and cultural sanitation and hygiene prac-
tices [25, 35]. Limited access to WASH facilities have been
revealed in western Madagascar (75% of schools had a
WASH score < 3); while no significant correlations were
found between WASH status and schistosomiasis preva-
lence or intensity, this may be due to an overall poor de-
gree of adequate WASH facilities [25].
In our study, whilst there was no significant difference
between sexes, prevalence and infection intensity in-
creased with age with both Kato-Katz and CCA, in keep-
ing with the literature [36]. This is unsurprising given
the absence of treatment with PZQ since 2008. By
downwardly extrapolating from the odds ratio of epg
values and CCA prevalence, pre-school ages (less than five
years of age) are also likely to have schistosomiasis, with
moderate intensities expected to be seen in three and four
year olds and low intensity infections in approximately
50% of two year olds. This indicates that testing and treat-
ing pre-school children should be considered in Maro-
lambo [14]. When made palatable for very young children,
PZQ has been shown to be safe, well tolerated and effect-
ive [37]. However, the WHO currently advises against
MDA treatment pre-school children due to the lack of
paediatric PZQ formulations. Pre-school children should
instead be treated on an individual basis by child-health
services, where their weight can be monitored and nutri-
ent supplements provided [21, 38].
Heavy infection intensities, determined by epg values
exceeding 400, were common in the study population.
Children with higher S. mansoni egg counts suffer from
a higher burden of disease, evidenced by presence of fae-
cal occult blood, faecal calprotectin, worsening degrees
of anaemia, fitness levels, growth rates and liver fibrosis
[8–12, 14, 39, 40].
Schistosomiasis associated morbidity and mortality
can be improved by implementing WHO guidance with
regular MDA [21]. Whilst PC is vital to control morbid-
ity, adjunctive approaches should be considered to re-
duce the prevalence of heavy infection intensities found
in Marolambo. These approaches should include health
education and encouragement of behavioural change,
the provision of safe water, sanitation and hygiene, and
snail control strategies [18].
The project had some limitations. Due to time con-
straints we were unable to screen for presence of soil-
transmitted helminths. Owing to errors with staining we
were unable to analyse faecal samples from one school
in Marolambo, so these samples could not be included
in our study. The study sites (schools) were purposively
selected due to the logistics of reaching each school,
proximity to the Nosivolo River and the fact that the dis-
ease had not been studied here before or the population
treated since 2008. Although our results demonstrate
high endemicity amongst these sites they do not repre-
sent the entire Marolambo district.
Non-school-attending SAC were not included in this
study. Some studies have shown that non-attenders have
similar or sometimes higher prevalence rates of infection
when compared to attending school children, and higher
infection intensities have been associated with poor at-
tendance rates [25, 41–45]. Although current WHO guid-
ance suggests MDA based in schools as the optimal
delivery location to treat SAC, efforts should also be made
to treat those who are not enrolled in schools [21, 46].
Conclusions
Intestinal schistosomiasis is hyperendemic among SAC
in the remote Marolambo district of Madagascar where
it is likely to have a considerable public health impact.
Prevalence rates of greater than 50% were found in each
village highlighting the vital need for annual PZQ treat-
ment in accordance with WHO guidelines. These results
have been shared with the Madagascar MOH to guide
the national MOH-led NTD-programme. In addition to
PC, improving health education, as well as access to safe
water, sanitation and hygiene would be suitable comple-
mentary measures to reduce the prevalence and burden
of schistosomiasis.
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